Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
2.800
-0.150 (-5.08%)
At close: Nov 20, 2024, 4:00 PM
2.820
+0.020 (0.71%)
Pre-market: Nov 21, 2024, 7:12 AM EST

Autolus Therapeutics Market Cap

Autolus Therapeutics has a market cap or net worth of $745.14 million as of November 21, 2024. Its market cap has increased by 15.78% in one year.

Market Cap
745.14M
Enterprise Value
389.25M
1-Year Change
15.78%
Ranking
Category
Stock Price
$2.80

Market Cap Chart

Since June 22, 2018, Autolus Therapeutics's market cap has decreased from $969.66M to $745.14M, a decrease of -23.15%. That is a compound annual growth rate of -4.02%.

History

DateMarket Cap% Change
Nov 19, 2024785.06M-29.92%
Dec 29, 20231.12B240.67%
Dec 30, 2022328.81M-13.12%
Dec 31, 2021378.45M-19.06%
Dec 31, 2020467.55M-21.26%
Dec 31, 2019593.77M-54.96%
Dec 31, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Embecta 832.06M
Liquidia 831.13M
Healthcare Services Group 823.06M
Relay Therapeutics 818.50M
Tyra Biosciences 817.93M
Cullinan Therapeutics 783.16M
AbCellera Biologics 782.72M
Avanos Medical 782.08M
Market Cap Rankings